Therapeutic Potential of Sitafloxacin as a New Drug Candidate for <i>Helicobacter</i> Eradication in Korea: An In Vitro Culture-Based Study

Therapeutic Potential of Sitafloxacin as a New Drug Candidate for <i>Helicobacter</i> Eradication in Korea: An In Vitro Culture-Based Study

Background: Increased prevalence of antibiotic resistance to <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection worldwide has driven the search for a new therapeutic candidate. Recently, sitafloxacin, a novel 4-quinolone agent, has emerged as a new therapeutic option for...

Full description

Bibliographic Details
Main Authors: Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Antibiotics
Subjects:
sitafloxacin
quinolone series
<i>Helicobacter pylori</i>
eradication
Online Access:https://www.mdpi.com/2079-6382/10/10/1242

Similar Items

Similar Items